Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment

Cited by (282)

Items 101–200 of 282

1. Methylphenidate‐Evoked Potentiation of Extracellular Dopamine in the Brain of Adolescents with Premature Birth: Correlation with Attentional Deficit
   NETO, PEDRO ROSA, LOU, HANS, CUMMING, PAUL, PRYDS, OLE, GJEDDE, ALBERT · 2002 · Annals of the New York Academy of Sciences
2. Plasticity of Dopamine D4 Receptors in Rat Forebrain Temporal Association with Motor Hyperactivity Following Neonatal 6-Hydroxydopamine Lesioning
   Kehong Zhang · 2002 · Neuropsychopharmacology
3. Investigating the Dopaminergic Synapse In Vivo. I. Molecular Imaging Studies in Humans
   S. Nikolaus, C. Antke, K. Kley, T. Poeppel, H. Hautzel, D. Schmidt, H. Müller · 2007 · Reviews in the Neurosciences
4. Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug–naive schizophrenic patients
   G. Schmitt, Thomas Frodl, Stefan Dresel, C. la Fougére, R. Bottlender, N. Koutsouleris, K. Hahn, H. Möller, E. Meisenzahl · 2006 · European Archives of Psychiatry and Clinical Neuroscience
5. Development of Tc-99m labeled tropanes: TRODAT-1, as a dopamine transporter imaging agent
   Hank F. Kung · 2001 · Nuclear Medicine and Biology
6. Interactions between genotype and retrospective ADHD symptoms predict lifetime smoking risk in a sample of young adults
   McClernon, F. Joseph, Fuemmeler, Bernard, Kollins, Scott, Kail, Melanie, Ashley-Koch, Allison · 2008 · Nicotine & Tobacco Research
7. Sequence analysis of Drd2, Drd4, and Dat1 in SHR and WKY rat strains
   Mill, Jonathan, Sagvolden, Terje, Asherson, Philip · 2005 · Behavioral and Brain Functions
8. PE2I: A Radiopharmaceutical for In vivo Exploration of the Dopamine Transporter
   Patrick Emond, Denis Guilloteau, Sylvie Chalon · 2008 · CNS Neuroscience & Therapeutics
9. Reinforcing and subjective effects of methylphenidate in adults with and without attention deficit hyperactivity disorder (ADHD)
   Kollins, Scott H., English, Joseph, Robinson, Rachel, Hallyburton, Matt, Chrisman, Allan K. · 2009 · Psychopharmacology
10. Expression studies of naturally occurring human dopamine transporter variants identifies a novel state of transporter inactivation associated with Val382Ala
    Michelle S. Mazei‐Robison, Randy Blakely · 2005 · Neuropharmacology
11. Spatial Attentional Bias as a Marker of Genetic Risk, Symptom Severity, and Stimulant Response in ADHD
    Mark A. Bellgrove, Edwina Barry, Katherine A. Johnson, Marie Cox, Aoife Dáibhis, Michael Daly, Ziarih Hawi, David Lambert, Michael Fitzgerald, Fiona McNicholas et al. · 2007 · Neuropsychopharmacology
12. Striatal dopamine transporter availability and DAT-1 gene in adults with ADHD: no higher DAT availability in patients with homozygosity for the 10-repeat allele
    J. Krause, S. Dresel, K. Krause, C. la Fougére, P. Zill, M. Ackenheil · 2006 · World Journal of Biological Psychiatry
13. Chronic Physical Activity for Attention Deficit Hyperactivity Disorder and/or Autism Spectrum Disorder in Children: A Meta-Analysis of Randomized Controlled Trials
    Meiqi Zhang, Zhan Liu, Hongtao Ma, Daniel M. Smith · 2020 · Frontiers in Behavioral Neuroscience
14. Complexes of the fac-{Re(CO)3}+ core with tridentate ligands derived from arylpiperazines
    Lihui Wei, Sangeeta Ray Banerjee, Murali K. Levadala, John W. Babich, Jon A. Zubieta · 2004 · Inorganica Chimica Acta
15. Dual-isotope SPECT imaging of striatal dopamine: First episode, drug naïve schizophrenic patients
    G. Schmitt, Christian Jean la Fougère, Stefan H. J. Dresel, Thomas Frodl, Klaus M. Hahn, H.‐J. Möller, Eva Maria Meisenzahl · 2007 · Schizophrenia Research
16. Genetic polymorphisms ofDAT1andCOMTdifferentially associate with actigraphy-derived sleep–wake cycles in young adults
    Amandine Valomon, Sebastian C. Holst, Valérie Bachmann, Antoine Viola, Christina Schmidt, Jurian Zuercher, Wolfgang Berger, Christian Cajochen, Hans‐Peter Landolt · 2014 · Chronobiology International
17. Prevalence of cocaine use and cocaine use disorder among adult patients with attention-deficit/hyperactivity disorder: A systematic review and meta-analysis.
    F. Oliva, C. Mangiapane, G. Nibbio, P. Berchialla, N. Colombi, F. Vigna-Taglianti · 2020 · Journal of Psychiatric Research
18. The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1
    G. Schmitt, E. Meisenzahl, T. Frodl, C. la Fougére, K. Hahn, H. Möller, S. Dresel · 2005 · Journal of Psychopharmacology
19. Impulsivity is related to striatal dopamine transporter availability in healthy males
    Anna Caroline Leite Costa, Christian Jean la Fougère, Oliver Michael Pogarell, Hans‐Jürgen Möller, Michael J Riedel, Ulrich Ettinger · 2012 · Psychiatry Research Neuroimaging
20. Age-related distribution of c-fos expression in the striatum of CD-1 mice after acute methylphenidate administration
    Marsha R. Penner, Melanie P. Leussis, Raphael Pinaud, NORMAND J. CARREY, H.A. Robertson, Richard E. Brown · 2002 · Developmental Brain Research
21. Dopamine Transporter in Attention-Deficit Hyperactivity Disorder Normalizes After Cessation of Methylphenidate
    FRANS J.M. FERON, Jos G.M. Hendriksen, Marinus J.P.G. van Kroonenburgh, Ciska Blom-Coenjaerts, Alfons G.H. Kessels, Jelle Jolles, Wim E.J. Weber, Johan S.H. Vles · 2005 · Pediatric Neurology
22. ADHD in adolescence and adulthood, with a special focus on the dopamine transporter and nicotine
    Johanna Krause, Klaus‐Henning Krause, Stefan H. J. Dresel, Christian Jean la Fougère, Manfred Ackenheil · 2006 · Dialogues in Clinical Neuroscience
23. A promoter polymorphism (−839 C > T) at the dopamine transporter gene is associated with attention deficit/hyperactivity disorder in Brazilian children
    Júlia Pasqualini Genro, Cristian Zeni, Guilherme V. Polanczyk, Tatiana Roman, Luís Augusto Rohde, Mara Helena Hutz · 2006 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
24. Deficit in working memory and abnormal behavioral tactics in dopamine transporter knockout rats during training in the 8-arm maze
    Natalia P. Kurzina, Irina Aristova, Anna B. Volnova, Raul R. Gainetdinov · 2020 · Behavioural Brain Research
25. Puppets, robots, critics, and actors within a taxonomy of attention for developmental disorders
    Maureen Dennis, Katia J. Sinopoli, Jack McKay Fletcher, Russell James Schachar · 2008 · Journal of the International Neuropsychological Society
26. Candidate system analysis in ADHD: Evaluation of nine genes involved in dopaminergic neurotransmission identifies association withDRD1
    Marta Ribasés, Josep Antoni Ramos‐Quiroga, Amaia Hervas G, Cristina Sánchez‐Mora, Rosa Bosch, Anna Bielsa, Xavier Gastaminza, Klaus‐Peter Lesch, Andreas Reif, Tobias Renner et al. · 2012 · The World Journal of Biological Psychiatry
27. Hyperactivity following postnatal NMDA antagonist treatment: Reversal by D-amphetamine
    Anders Fredriksson, Trevor Archer · 2003 · Neurotoxicity Research
28. Association between the dopamine transporter gene and the inattentive subtype of attention deficit hyperactivity disorder in Taiwan
    Chi‐Yung Shang, Susan Shur‐Fen Gau, Chih‐Min Liu, Hai‐Gwo Hwu · 2010 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
29. The acute effect of methylphenidate on cerebral blood flow in boys with attention-deficit/hyperactivity disorder
    Cláudia Maciel Szobot, Carla Ruffoni Ketzer, Renato D. Cunha, Maria Alice de Mattos Pimenta Parente, Daniel D. Langleben, Paul D. Acton, Flávio Pereira Kapczinski, Luís Augusto Rohde · 2003 · European Journal of Nuclear Medicine and Molecular Imaging
30. The influence of methylphenidate on the power spectrum of ADHD children – an MEG study
    Christian Wienbruch, Isabella Paul, Susanne M. Bauer, H Kivelitz · 2005 · BMC Psychiatry
31. Methylphenidate DAT binding in adolescents with Attention-Deficit/ Hyperactivity Disorder comorbid with Substance Use Disorder - a single Photon Emission Computed Tomography with [Tc99m]TRODAT-1 study
    Cláudia Maciel Szobot, Ming Chi Shih, Thais Schaefer, Neivo Júnior, Marcelo Q. Hoexter, Ying Kai Fu, Flávio Pechansky, Rodrigo A. Bressan, Luís Augusto Rohde · 2008 · NeuroImage
32. ADHD and the Dopamine Transporter: Are There Reasons to Pay Attention?
    Michelle S. Mazei‐Robison, Randy Blakely · 2006 · Springer eBooks
33. Neurobiologie der Aufmerksamkeitsdefizit-/ Hyperaktivitätsstörung (ADHS)
    Tobias Banaschewski, Veit Roessner, Henrik Uebel, Aribert Rothenberger · 2004 · Kindheit und Entwicklung
34. Elevated striatal dopamine transporter in a drug naive patient with Tourette syndrome and attention deficit/ hyperactivity disorder: positive effect of methylphenidate
    Klaus‐Henning Krause, Stefan H. J. Dresel, Johanna Krause, Hank F. Kung, Klaus Tatsch, Hanns Lochmüller · 2002 · Journal of Neurology
35. Neurogenetic interactions and aberrant behavioral co-morbidity of attention deficit hyperactivity disorder (ADHD): dispelling myths
    David E. Comings, Thomas J.H. Chen, Kenneth Blum, Julie F. Mengucci, Seth H. Blum, Brian Meshkin · 2005 · Theoretical Biology and Medical Modelling
36. Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine
    Kurt P. Schulz, Anne‐Claude Bedard, Jin Fan, Tom Hildebrandt, Mark A. Stein, Iliyan Ivanov, Jeffrey M. Halperin, Jeffrey H. Newcorn · 2017 · Journal of the American Academy of Child & Adolescent Psychiatry
37. Searching for a Neurobiological Basis for Self-Medication Theory in ADHD Comorbid With Substance Use Disorders
    Neivo Silva, Cláudia Maciel Szobot, Ming Chi Shih, Marcelo Q. Hoexter, Carlos Eduardo Anselmi, Flávio Pechansky, Rodrigo A. Bressan, Luís Augusto Rohde · 2013 · Clinical Nuclear Medicine
38. Dopamine transporter 3'UTR VNTR genotype is a marker of performance on executive function tasks in children with ADHD
    S. Karama, N. Grizenko, E. Sonuga-Barke, A. Doyle, J. Biederman, Valentin Mbékou, A. Polotskaia, Marina Ter-Stepanian, Rosherrie de Guzman, Johanne Bellingham et al. · 2008 · BMC Psychiatry
39. Brain SPECT with short focal-length cone-beam collimation
    Mi‐Ae Park, Steven C. Moore, Marie Foley Kijewski · 2005 · Medical Physics
40. Neurobiology of Attention Deficit Hyperactivity Disorder
    Stephen V. Faraone, Nevena V. Radonjić · 2023 · Springer eBooks
41. Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: On the path to an animal model of attention-deficit hyperactivity disorder
    Marc A. Mergy, Raajaram Gowrishankar, Gwynne L. Davis, Tammy N. Jessen, Jane Wright, Gregg D. Stanwood, Maureen K. Hahn, Randy Blakely · 2013 · Neurochemistry International
42. Synthesis and biological evaluation of a series of novel N- or O-fluoroalkyl derivatives of tropane: potential positron emission tomography (PET) imaging agents for the dopamine transporter
    Xiao‐Hui Gu, Rushi Zong, Nora S. Kula, Ross J. Baldessarini, John L. Neumeyer · 2001 · Bioorganic & Medicinal Chemistry Letters
43. Quantitation of dopamine transporter blockade by methylphenidate: first in vivo investigation using [123I]FP-CIT and a dedicated small animal SPECT
    Nikolaus, Susanne, Wirrwar, Andreas, Antke, Christina, Arkian, Shahram, Schramm, Nils, M�ller, Hans-Wilhelm, Larisch, Rolf · 2005 · European Journal of Nuclear Medicine and Molecular Imaging
44. Changes in EEG Spectrograms, Event-Related Potentials and Event-Related Desynchronization Induced by Relative Beta Training in ADHD Children
    Jury D. Kropotov, Vera A. Grin-Yatsenko, Valery A. Ponomarev, Leonid Semenovich Chutko, Elena A. Yakovenko, Nikishena Is · 2007 · Journal of Neurotherapy
45. Assessing the molecular genetics of the development of executive attention in children: focus on genetic pathways related to the anterior cingulate cortex and dopamine
    Karin Cecilia Brocki, Suzanne M. Clerkin, Kevin G. Guise, Jin Fan, John Fossella · 2009 · Neuroscience
46. Clinical and neurobiological factors in the management of treatment refractory attention-deficit hyperactivity disorder
    Se-Hoon Shim, Hee-Jung Yoon, Jeongjae Bak, Sang‐Woo Hahn, Yong‐Ku Kim · 2016 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
47. Brain perfusion and dopaminergic genes in boys with attention‐deficit/hyperactivity disorder
    Cláudia Maciel Szobot, Tatiana Roman, Renato D. Cunha, Paul D. Acton, Mara Helena Hutz, Luís Augusto Rohde · 2004 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
48. Molecular imaging genetics of methylphenidate response in ADHD and substance use comorbidity
    Cláudia Maciel Szobot, Tatiana Roman, Mara Helena Hutz, Júlia Pasqualini Genro, Ming Chi Shih, Marcelo Q. Hoexter, Neivo Júnior, Flávio Pechansky, Rodrigo A. Bressan, Luís Augusto Rohde · 2010 · Synapse
49. Response to methylphenidate is not influenced by DAT1 polymorphisms in a sample of Brazilian adult patients with ADHD
    Contini, Verônica, Victor, Marcelo M., Marques, Francine Z. C., Bertuzzi, Guilherme P., Salgado, Carlos A. I., Silva, Katiane L., Sousa, Nyvia O., Grevet, Eugenio H., Belmonte-de-Abreu, Paulo, Bau, Claiton H. D. · 2010 · Journal of Neural Transmission
50. Imaging neurochemical endophenotypes: promises and pitfalls
    Diana Martínez, Allegra I. Broft, Marc A. Laruelle · 2001 · Pharmacogenomics
51. Impaired transcallosally mediated motor inhibition in adults with attention-deficit/hyperactivity disorder is modulated by methylphenidate
    Jacqueline Hoeppner, Roland Wandschneider, Martin Neumeyer, Wolfgang Gierow, Frank Haessler, Sabine Christiane Herpertz, Johannes A Buchmann · 2008 · Journal of Neural Transmission
52. Effects of neonatal 6-hydroxydopamine lesion on the gene expression profile in young adult rats
    Yoshinori Masuo, Masami Ishido, Masatoshi Morita, Syuichi Oka · 2002 · Neuroscience Letters
53. Neural and Behavioral Endophenotypes in ADHD
    Natalia del Campo, Ulrich Müller, Barbara Jacquelyn Sahakian · 2012 · Current topics in behavioral neurosciences
54. Cyclopentadienyl technetium (99mTc) tricarbonyl piperidine conjugates: biodistribution and imaging studies
    Mouldi Saidi, Kanchan Kothari, M.R.A. Pillai, Amri Hassan, Haladhar Dev Sarma, Pradip R. Chaudhari, T. P. Unnikrishnan, Aruna G. Korde, Zohra Azzouz · 2001 · Journal of Labelled Compounds and Radiopharmaceuticals
55. Neuroimagem no transtorno de déficit de atenção/hiperatividade
    Cláudia Maciel Szobot, Mariana Eizirik, Renato D. Cunha, Daniel D. Langleben, Luís Augusto Rohde · 2001 · Brazilian Journal of Psychiatry
56. Increased symptoms of attention deficit hyperactivity disorder and major depressive disorder symptoms in nail‐patella syndrome: Potential association with LMX1B loss‐of‐function
    Carmen López‐Arvizu, Elizabeth P. Sparrow, Michael Strube, Chris Slavin, Caroline DeOleo, Justin James, Julie Elizabeth Hoover-Fong, Iain McIntosh, Elaine Tierney · 2010 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
57. Strengths and limitations of genetic models of ADHD
    Gainetdinov, Raul R. · 2010 · ADHD Attention Deficit and Hyperactivity Disorders
58. Comparative efficacy and safety of methylphenidate and atomoxetine for attention-deficit hyperactivity disorder in children and adolescents: Meta-analysis based on head-to-head trials
    Qiang Liu, Hong Zhang, Qingqing Fang, Lili Qin · 2017 · Journal of Clinical and Experimental Neuropsychology
59. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence
    Cleo Lina Crunelle, Wim van den Brink, Dick J. Veltman, Katelijne van Emmerik‐van Oortmerssen, Geert Dom, Robert A. Schoevers, Jan Booij · 2013 · European Neuropsychopharmacology
60. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
    Raissa Carolina Fonseca Cândido, Cristiane A Menezes de Padua, Su Golder, Daniela R. Junqueira · 2021 · Cochrane Database of Systematic Reviews
61. Activity‐dependent regulation of the dopamine transporter is mediated by Ca2+/calmodulin‐dependent protein kinase signaling
    Shalini Padmanabhan, Nevin A. Lambert, Balakrishna M. Prasad · 2008 · European Journal of Neuroscience
62. Prepuberal intranasal dopamine treatment in an animal model of ADHD ameliorates deficient spatial attention, working memory, amino acid transmitters and synaptic markers in prefrontal cortex, ventral and dorsal striatum
    Lucia A. Ruocco, Concetta Treno, U.A. Gironi Carnevale, Claudio Arra, Claudia Mattern, J.P. Huston, M.A. de Souza Silva, Susanne Nikolaus, Antonella Scorziello, Maria Nieddu et al. · 2014 · Amino Acids
63. Dopamine transporter gene susceptibility to methylation is associated with impulsivity in nonhuman primates
    Abigail Z. Rajala, Ismail S. Zaitoun, Jeffrey B. Henriques, Alexander K. Converse, Dhanabalan Murali, Miles L. Epstein, Luis C. Populin · 2014 · Journal of Neurophysiology
64. Rodent models: Utility for candidate gene studies in human attention-deficit hyperactivity disorder (ADHD)
    Jonathan S. Mill · 2007 · Journal of Neuroscience Methods
65. Differential Expression of SLC9A9 and Interacting Molecules in the Hippocampus of Rat Models for Attention Deficit/Hyperactivity Disorder
    Yanli Zhang‐James, Frank A. Middleton, Terje Sagvolden, Stephen V. Faraone · 2012 · Developmental Neuroscience
66. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
    Raissa Carolina Fonseca Cândido, Menezes de Padua, Cristiane A, Su Golder, Daniela R. Junqueira · 2021 · White Rose Research Online (University of Leeds, The University of Sheffield, University of York)
67. Attention Deficit/Hyperactivity Disorder: Is There a Correlation Between Dopamine Transporter Density and Cerebral Blood Flow?
    da Silva, Neivo, Szobot, Claudia M., Anselmi, Carlos E., Jackowski, Andrea P., Chi, Shih M., Hoexter, Marcelo Q., Anselmi, Osvaldo E., Pechansky, Flavio, Bressan, Rodrigo A., Rohde, Luis A. · 2011 · Clinical Nuclear Medicine
68. Association of the dopamine transporter gene and ADHD symptoms in a Canadian population‐based sample of same‐age twins
    I. Ouellet-Morin, K. Wigg, Yu Feng, G. Dionne, P. Robaey, M. Brendgen, F. Vitaro, L. Simard, R. Schachar, R. Tremblay et al. · 2008 · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
69. Behavioural characteristics and gene expression in the hyperactive wiggling (Wig) rat
    Yoshinori Masuo, Masami Ishido, Masatoshi Morita, Hirofumi Sawa, Kazuo Nagashima, Etsuo Niki · 2007 · European Journal of Neuroscience
70. Birth insult and stress interact to alter dopamine transporter binding in rat brain
    Bassem F. El‐Khodor, Patricia Boksa · 2002 · Neuroreport
71. Evaluation of electroretinography (ERG) parameters as a biomarker for ADHD
    Marc-André Dubois, Charles-Antoine Pelletier, Chantal Mérette, Valérie Jomphe, Rose Turgeon, Richard E. Bélanger, Simon Grondin, Marc Hébert · 2023 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
72. Modelling human drug abuse and addiction with dedicated small animal positron emission tomography
    Jeffrey W. Dalley, Tim D. Fryer, Franklin I. Aigbirhio, Laurent Brichard, Hugh K. Richards, Young T. Hong, Jean‐Claude Baron, Barry J. Everitt, Trevor William Robbins · 2008 · Neuropharmacology
73. Prefrontal grey and white matter neurometabolite changes after atomoxetine and methylphenidate in children with attention deficit/hyperactivity disorder: A 1H magnetic resonance spectroscopy study
    Veronika Marcincakova Husarova, Michal Bittšanský, Igor Ondrejka, Dušan Dobrota · 2014 · Psychiatry Research Neuroimaging
74. Methylphenidate does not increase ethanol consumption in a rat model for attention-deficit hyperactivity disorder—the spontaneously hypertensive rat
    Heleen Suzanne Soeters, Fleur Margaret Howells, Vivienne Ann Russell · 2008 · Metabolic Brain Disease
75. Behavioural characterisation of rats exposed neonatally to bisphenol-A: responses to a novel environment and to methylphenidate challenge in a putative model of attention-deficit hyperactivity disorder
    Motori Kiguchi, Satoshi Fujita, Hidero Oki, Noriyoshi Shimizu, Alexander Rudolf Cools, Noriaki Koshikawa · 2008 · Journal of Neural Transmission
76. The Association Between Parkinson’s Disease and Attention-Deficit Hyperactivity Disorder
    Hueng‐Chuen Fan, Yu‐Kang Chang, Jeng‐Dau Tsai, Kuo-Liang Chiang, Jui‐Hu Shih, Kuan-Yi Yeh, Kuo‐Hsing Ma, I‐Hsun Li · 2020 · Cell Transplantation
77. Motor activity and gene expression in rats with neonatal 6‐hydroxydopamine lesions
    Yoshinori Masuo, Masami Ishido, Masatoshi Morita, Syuichi Oka, Etsuo Niki · 2004 · Journal of Neurochemistry
78. Pharmacological challenge and synaptic response – assessing dopaminergic function in the rat striatum with small animal single-photon emission computed tomography (SPECT) and positron emission tomography (PET)
    Susanne Nikolaus, Rolf Larisch, Henning Vosberg, Markus Beu, Andreas Wirrwar, Christina Antke, Konstantin Kley, Maria A. de Souza Silva, Joseph P. Huston, Hans‐Wilhelm Müller · 2011 · Reviews in the Neurosciences
79. A New Paradigm for Training Hyperactive Dopamine Transporter Knockout Rats: Influence of Novel Stimuli on Object Recognition
    Natalia P. Kurzina, Anna B. Volnova, Irina Aristova, Raul R. Gainetdinov · 2021 · Frontiers in Behavioral Neuroscience
80. Behavioral responses to methylphenidate and apomorphine in rats exposed neonatally to bisphenol-A
    Motori Kiguchi, Satoshi Fujita, Jun Lee, Noriyoshi Shimizu, Noriaki Koshikawa · 2007 · Journal of Oral Science
81. Associations between the Mismatch-negativity Potential and Symptom Severity in Medication-naïve Children and Adolescents with Symptoms of Attention Deficit/hyperactivity Disorder
    Yeon Jung Lee, Mi Young Jeong, Jungho Kim, Ji-Sun Kim · 2020 · Clinical Psychopharmacology and Neuroscience
82. Evidence-based psychopharmacology for children and adolescents
    David Coghill · 2002 · Current Opinion in Psychiatry
83. Dual-isotope SPECT imaging of striatal dopamine: a comparative study between never-treated and haloperidol-treated first-episode schizophrenic patients
    G. Schmitt, Stefan Dresel, Thomas Frodl, C. la Fougére, R. Boerner, K. Hahn, H. Möller, E. Meisenzahl · 2012 · European Archives of Psychiatry and Clinical Neuroscience
84. Effects of methylphenidate in ADHD adults on target evaluation processing reflected by event-related potentials
    Martin D. Ohlmeier, Vanessa Prox-Vagedes, Yuanyuan Zhang, Markus Zedler, Marc Ziegenbein, H. M. Emrich, Detlef E. Dietrich · 2007 · Neuroscience Letters
85. Rats Lacking the Dopamine Transporter Display Inflexibility in Innate and Learned Behavior
    Anastasia D. Belskaya, Natalia P. Kurzina, A. A. Savchenko, Ilya Sukhanov, Arina A. Gromova, Raul R. Gainetdinov, Anna B. Volnova · 2024 · Biomedicines
86. Noise benefit in prepulse inhibition of the acoustic startle reflex
    Erik Pålsson, Göran B. W. Söderlund, Daniel Klamer, Filip Bergquist · 2010 · Psychopharmacology
87. Effects of methylphenidate hydrochloride on the cardiovascular system in vivo and in vitro: A safety pharmacology study
    Akihide Wakamatsu, Shunji Nomura, Yoshiki Tate, Shigekazu Shimizu, Yasushi Harada · 2009 · Journal of Pharmacological and Toxicological Methods
88. Investigating possible causal effects of externalizing behaviors on tobacco initiation: A Mendelian randomization analysis
    Meg Fluharty, Hannah Sallis, Marcus Robert Munafo · 2018 · Drug and Alcohol Dependence
89. Possible involvements of glutamate and adrenergic receptors on acute toxicity of methylphenidate in isolated hippocampus and cerebral cortex of adult rats
    Majid Motaghinejad, Manijeh Motevalian, Behnaz Shabab · 2016 · Fundamental and Clinical Pharmacology
90. The Lack of Dopamine Transporter Is Associated With Conditional Associative Learning Impairments and Striatal Proteomic Changes
    A. A. Savchenko, Carina Müller, Jana Lubec, Damiana Leo, Volker Korz, Leila Afjehi-Sadat, Jovana Maliković, Fernando J. Sialana, Gert Lübec, Ilya Sukhanov · 2022 · Frontiers in Psychiatry
91. Noradrenergic Modulation of Learned and Innate Behaviors in Dopamine Transporter Knockout Rats by Guanfacine
    Anna B. Volnova, Natalia P. Kurzina, Anastasia D. Belskaya, Arina A. Gromova, Arseniy Pelevin, Maria A. Ptukha, Zoia S. Fesenko, Alla Ignashchenkova, Raul R. Gainetdinov · 2023 · Biomedicines
92. Human Brain Imaging of Dopamine Transporters
    Andrea Varrone, Christer Halldin · 2014 · Elsevier eBooks
93. Synthesis and amine transporter affinities of novel phenyltropane derivatives as potential positron emission tomography (PET) imaging agents
    Xuemei Peng, Ao Zhang, Nora S. Kula, Ross J. Baldessarini, John L. Neumeyer · 2004 · Bioorganic & Medicinal Chemistry Letters
94. Gene Organization and Polymorphisms of Monoamine Transporters: Relationship to Psychiatric and Other Complex Diseases
    Maureen K. Hahn, Randy Blakely · 2003 · Humana Press eBooks
95. Brain Imaging Data of ADHD
    Amir Raz · 2004
96. Study of 99mTc-TRODAT-1 imaging on human brain with children autism by single photon emission computed tomography
    Xiao-mian Sun, Yue Jing, Chongxun Zheng, Min Liu, Huixing Deng · 2005 · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
97. Dopamine transporter gene polymorphism in children with ADHD: A pilot study in Indonesian samples
    Tjhin Wiguna, Raden Irawati Ismail, Noorhana Setiawati Winarsih, Fransiska Kaligis, Anggia Hapsari, Lina Budiyanti, Rini Sekartini, Susan Rahayu, Anthony P. S. Guerrero · 2017 · Asian Journal of Psychiatry
98. Caudate nucleus neurons participate in methylphenidate function: Behavioral and neuronal recordings from freely behaving adolescent rats
    Tahseen J. Karim, Ceren Aksel, Natasha Kharas, Cruz Reyes-Vasquez, Nachum Dafny · 2018 · Brain Research Bulletin
99. Synthesis and radiopharmacological characterization of 2β-carbo-2′-[18F]fluoroethoxy-3β-(4-bromo-phenyl)tropane ([18F]MCL-322) as a PET radiotracer for imaging the dopamine transporter (DAT)
    Frank R. Wuest, Mathias Berndt, Klaus Strobel, Joerg van den Hoff, Xuemei Peng, John L. Neumeyer, Ralf Bergmann · 2007 · Bioorganic & Medicinal Chemistry
100. What have positron emission tomography and ‘Zippy’ told us about the neuropharmacology of drug addiction?
     Paul D. Cumming, Daniele Caprioli, Jeffrey W. Dalley · 2010 · British Journal of Pharmacology